Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 331.50
Bid: 330.50
Ask: 332.00
Change: 6.50 (2.00%)
Spread: 1.50 (0.454%)
Open: 320.00
High: 335.00
Low: 320.00
Prev. Close: 325.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Irvine Electronics

26 Aug 2021 07:00

RNS Number : 8157J
Volex PLC
26 August 2021
 

26 August 2021

Volex plc

("Volex" or the "Company")

Acquisition of Irvine Electronics, Inc. for $16.4 million

Expands geographic coverage and technical capability in key North American market

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is pleased to announce that it has signed a share purchase agreement for the acquisition of the entire issued share capital of Irvine Electronics, Inc. ("Irvine"), for a total consideration of $16.4 million (the "Acquisition"). The Acquisition will be satisfied in cash at completion from the Company's existing debt facilities and will be earnings enhancing from completion. The Acquisition is expected to complete in Q3 FY2022, subject to customary closing conditions including regulatory approvals in the US.

 Strategic Rationale

· Irvine is a US-based manufacturer of electronic solutions, including printed circuit board assemblies, with over 30 years of experience and deep relationships across a wide variety of blue-chip customers, particularly in the defence, military aerospace and medical markets

· The Acquisition will strengthen Volex's existing profile in North America, adding further capabilities and capacity in California to complement the Group's existing operations in Washington state and Mexico, creating a compelling value proposition for customers in the region

· Expanding on our integrated manufacturing services strategy, the Acquisition will further strengthen Volex's ability to provide customers with vertically integrated solutions through enhanced printed circuit board assembly capabilities

Transaction Highlights

· Earnings-enhancing from completion

· Consideration represents 3.5x adjusted1 EBITDA for the year ended 31 December 2020

· Irvine delivering current annual run rate adjusted1 EBITDA c.$3-4m

· Implementing the Volex continuous improvement methodology and deploying incremental investment in capabilities and infrastructure will be value enhancing

· Grow Volex's capabilities and profile in the significant and attractive US defence market, providing opportunities to support long-term customer programmes

· On completion of the transaction, the Company will still have financial flexibility to continue to progress opportunities in its exciting acquisition pipeline

Commenting on the Acquisition, Nat Rothschild, Executive Chairman of Volex said:

"The acquisition of Irvine increases our geographic coverage and technical capabilities in the key North American market. Our strategic intent is to develop Volex's presence in the defence and military aerospace markets, adding further blue-chip customers involved in long-term programmes and partnerships.

With advanced manufacturing located in Southern California, in the centre of one of the most dynamic electronics manufacturing environments in North America, Irvine will enhance our footprint, further complementing our total integrated manufacturing solutions strategy and strengthening our global capabilities in new and existing markets.

This acquisition is indicative of our ongoing M&A strategy which, along with our pursuit of operational excellence and organic growth, will assist Volex as we target $650 million in revenues and $65 million of underlying operating profit by 2024."

About Irvine

Irvine, a US based manufacturer of electronic solutions, was founded in 1990. The company has a very stable customer base which it supports on long-term projects. Most of these customers are in the defence sector with other significant customers in aerospace, medical and complex industrial technology sectors. It has a 50,000 square foot manufacturing site which provides ample capacity to grow and is accredited to stringent international quality standards. In the year ended 31 December 2020, Irvine generated revenues of $26.6 million, EBITDA of $8.4 million and profit before tax of $9.6 million. The net assets of Irvine as at 31 December 2020 were $4.3 million. The results of the year ended 31 December 2020 include a significant non-recurring customer project for Covid-19 related medical equipment which has now been substantially completed. Excluding the impact of this one-off project and other non-recurring Covid-related adjustments, the adjusted1 EBITDA and adjusted1 profit before tax for the year ended 31 December 2020 are $4.7 million and $4.6 million respectively.

 

1. Adjusted performance measures exclude certain projects, government support and one-off items that arose as a result of the Covid-19 pandemic and are not expected to be a feature of the performance of the business in future financial periods

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of Volex plc is Christian Bedford, Group General Counsel & Company Secretary.

For further information please contact:

Volex plc

+44 (0)7971 156 431

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Christian Bedford, Group General Counsel and Company Secretary

 

 

Singer Capital Markets - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

George Tzimas

 

 

HSBC Bank plc - Joint Broker

+44 (0)20 7991 8888

Simon Alexander

Joe Weaving

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

Ollie Head

 

About Volex

 

Volex plc (AIM:VLX) is a global leader in integrated manufacturing for performance-critical applications and a supplier of power products. We serve a diverse range of markets and customers, with particular expertise in cable assemblies, higher-level assemblies, data centre power and connectivity, electric vehicles and consumer electricals. We are headquartered in the UK and operate from 17 manufacturing locations with a global workforce of over 6,300 employees across 21 countries. Our products are sold through our own locally based sales teams and through authorised distributor partners to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services ('EMS') companies worldwide.

 

All of the products and services that we offer are integral to the increasingly complex digital world in which we live, providing power and connectivity from the most common household items to the most complex medical equipment. For more information, please visit www.volex.com

 

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBPKBKBCFB
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20245:13 pmRNSDirector/PDMR Shareholding
16th Jan 202412:33 pmRNSDirector/PDMR Shareholding
10th Jan 20244:45 pmRNSIssue of Equity
22nd Dec 202311:00 amRNSDirector/PDMR Shareholding
7th Dec 20233:42 pmRNSScrip Reference Price
23rd Nov 20237:00 amRNSHalf-year report
8th Nov 20237:15 amRNSAnalyst Briefing & Investor Presentation
24th Oct 20237:00 amRNSUpdate on H1 Trading and Cyber Incident
20th Oct 20237:00 amRNSDirectorate Changes
9th Oct 20237:00 amRNSNotice of Cyber Incident
28th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSCompletion of Murat Ticaret Acquisition
30th Aug 20235:00 pmRNSDirector/PDMR Shareholding
21st Aug 20234:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20237:00 amRNSReceipt of Competition Clearance for Murat Ticaret
27th Jul 20236:23 pmRNSResult of AGM
27th Jul 202311:37 amRNSScrip Reference Price
27th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20234:40 pmRNSDirector/PDMR Shareholding
28th Jun 20234:59 pmRNSHolding(s) in Company
27th Jun 202310:00 amRNSNotice of AGM and Publication of Annual Report
22nd Jun 20231:00 pmRNSResults of Fundraising
22nd Jun 20237:02 amRNSREX Retail Offer
22nd Jun 20237:01 amRNSAcquisition of Murat Ticaret and Proposed Placing
22nd Jun 20237:00 amRNSPreliminary Group Results FY2023
12th Jun 20237:00 amRNSNotice of Results and Investor Presentation
18th May 20237:00 amRNSChange of Adviser
27th Apr 20237:00 amRNSEV Contract Win
18th Apr 20237:00 amRNSFull Year Trading Update
18th Jan 20237:00 amRNSAnalyst Site Visit
22nd Dec 202210:03 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20227:00 amRNSScrip Reference Price
9th Nov 20227:00 amRNSHalf-year Report of Volex plc
13th Oct 20227:00 amRNSNotice of Half Year Results
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20223:58 pmRNSDirector / PDMR Dealing
30th Aug 20223:36 pmRNSDirector / PDMR Dealing
19th Aug 20225:32 pmRNSResults of AGM, Issue of Equity and TVR
19th Aug 20227:00 amRNSAGM Statement
29th Jul 20224:00 pmRNSScrip Dividend Scheme and Scrip Reference Price
11th Jul 202210:53 amRNSNotice of AGM and Publication of Annual Report
29th Jun 20225:08 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSPreliminary Group Results FY2022
8th Jun 20227:00 amRNSNotice of Preliminary Results & IMC Presentation
19th May 20227:00 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.